Navigating Due Diligence in Cell and Gene Therapy: Key Risks and Strategic Insights
March 17, 2025
The Cell and gene Therapy (CGT) industry is experiencing rapid growth. It offers groundbreaking treatments
The Cell and gene Therapy (CGT) industry is experiencing rapid growth. It offers groundbreaking treatments
Since 2021, the Pharma Manufacturing World Summit has gathered SVPs and VPs of
Introduction Cell and gene therapy evolution has undergone remarkable advancements, transforming the landscape
Introduction In 1991, James Watson said, “Many people say they are worried about
Cell therapy and gene therapy are cutting-edge approaches in modern medicine, aiming to
The FDA has released a draft guidance titled “Rare Diseases: Early Drug Development
At Compliance Architects®, we take pride in our team of experienced experts. They
Organ transplantation stands as a sign of hope for those battling organ failure,
The U.S. Food and Drug Administration (FDA) has introduced industry guidance that outlines
Diluks De Silva was honored to speak with Geoff Mix, Head of Content
© 2009-2025 Compliance Architects Holdings LLC – used by permission. All copyrights, trademarks and other intellectual property are the property of Compliance Architects Holdings LLC and are used by permission.
